1.
Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents with Moderate-to-Severe AD and Skin of Color. J of Skin. 2025;9(6):s625. doi:10.25251/0262jz84